Home Cart 0 Sign in  

[ CAS No. 1589527-65-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1589527-65-0
Chemical Structure| 1589527-65-0
Structure of 1589527-65-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1589527-65-0 ]

Related Doc. of [ 1589527-65-0 ]

Alternatived Products of [ 1589527-65-0 ]

Product Details of [ 1589527-65-0 ]

CAS No. :1589527-65-0 MDL No. :MFCD29477497
Formula : C28H25F3N6O Boiling Point : -
Linear Structure Formula :- InChI Key :NOHQEAFAESMMDX-UHFFFAOYSA-N
M.W : 518.53 Pubchem ID :73425700
Synonyms :
IRE1 Inhibitor IV;IRE1α Kinase Inhibiting RNase Attenuator 6

Safety of [ 1589527-65-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1589527-65-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1589527-65-0 ]

[ 1589527-65-0 ] Synthesis Path-Downstream   1~3

  • 1
  • [ 1320267-01-3 ]
  • [ 1414938-25-2 ]
  • [ 1589527-65-0 ]
YieldReaction ConditionsOperation in experiment
53 mg With tetrakis(triphenylphosphine) palladium(0); sodium carbonate In water; N,N-dimethyl-formamide at 85℃; 1 -(4-(8-amino-3 -tert-butylimidazo[ 1 ,5-a]pyrazin- 1 -yl)naphthalen- 1 -yl)-3 -(3- (trifluoromethyl)phenyl)urea (KIRA6). A mixture of l-iodo-3-tertbutylimidazo[l,5-a]pyrazin-8- amine (60.0 mg, 0.120 mmol), 3 (66 mg, 0.15 mmol), tetrakis(triphenylphosphine)palladium (5 mg, 4 μηιο) and sodium carbonate (928 mg, 0.27 mmol) was dissolved in a 3: 1 mixture of DME/water (0.5 mL). The mixture was heated overnight at 85 °C. The crude mixture was cooled to room temperature, diluted in a mixture of acetonitrile/water and purified by reverse phase chromatography (HPLC) to obtain 53 mg of KIRA6. TLC (CH2C12:MeOH, 95:5 v/v): Rf = 0.4; 1H NMR (300 MHz, MeOD): δ 8.26 (m, 1H), 8.08-7.99 (m, 2H), 7.90-7.86 (m, 1H), 7.83-7.79 (m, 1H), 7.69- 7.52 (m, 5H), 7.35 (d, J = 7.4 Hz, 1H), 6.98 (m, 1H), 1.65 (s, 9H); 13C NMR (126 MHz, MeOD): δ 154.8, 140.2, 135.7, 133.0, 132.4, 131.7, 131.6, 131.0, 130.7, 129.4, 128.8, 128.6, 128.5, 127.0, 126.6, 125.9, 125.4, 123.2, 121.9, 120.1, 118.7, 115.0, 114.4, 110.1, 33.6, 27.3; ESI-MS (m/z): [M]+ calcd. for C28H25F3N60 (M+H+): 519.2; found 519.4.
  • 2
  • [ 329-01-1 ]
  • [ 1589527-65-0 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 1: tetrahydrofuran / 20 °C 2: tetrakis(triphenylphosphine) palladium(0); sodium carbonate / N,N-dimethyl-formamide; water / 85 °C
  • 3
  • [ 1218790-22-7 ]
  • 1-(4-(8-amino-3-tert-butylimidazo[1,5-a]pyrazin-1-yl)naphthalen-1-yl)-3-(3-(trifluoromethyl)phenyl)urea [ No CAS ]
Same Skeleton Products
Historical Records